18th Annual NATA Symposium

17th Annual NATA Symposium, Prague 2015The 18th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis will take place at the Firenze Fiera Congress & Exhibition Center in Florence, Italy, on April 20-21, 2017.

The deadline for abstract submission is December 19, 2016.

The first announcement can be downloaded here in PDF format and here in Powerpoint format.

More information will be posted on Nataonline shortly.

Follow NATA on LinkedIn and Twitter

Join NATA's group on LinkedIn and follow NATA on Twitter (@NATAforum) to receive the latest news on patient blood management, haemostasis and thrombosis, and to participate in discussions with colleagues in the field.
LinkedIn Group / Twitter

Slide Presentations from the 16th Annual NATA Symposium, Prague, 2015

We are pleased to provide NATA members with PDF versions of presentations delivered at past NATA symposia. These presentations are made available for NATA members with permission from the authors and may have been modified to remove unpublished or copyrighted material.

To access presentations from the 16th Annual NATA Symposium, which was held in Prague on April 16-17, 2015, please log-in and go to the "Members' Area" section or click on the link below.
Slide Presentations from the 16th Annual NATA Symposium

News

European Medicines Agency's Committee for Medicinal Products for Human Use recommends marketing authorisation for idarucizumab (Praxbind), a specific reversal agent for dabigatran

On 24 September 2015, the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Praxbind, a specific reversal agent for dabigatran, intended for use when rapid reversal of the anticoagulant effects of Pradaxa (dabigatran etexilate) is required inadult patients.

The full indication is: “Praxbind is a specific reversal agent for dabigatran and is indicated in adult patients treated with Pradaxa (dabigatran etexilate) when rapid reversal of its anticoagulant effects is required:
• For emergency surgery/urgent procedures
• In life-threatening or uncontrolled bleeding."
Read more on this

From the Literature

May 31, 2016

Published: Jun 2016

Gonzalez E, Moore EE, Moore HB, et al.

Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays.
Ann Surg 2016;263:1051-1059.

#

NATA REVIEW:
In a pragmatic RCT, Gonzalez and colleagues from Denver, CO, USA, show that resuscitation guided by a viscoelastic...
REVIEW by:
J. Stensballe

Published: Apr 2016

Stevens LM, Noiseux N, Prieto I, Hardy JF

Major transfusions remain frequent despite the generalized use of tranexamic acid: an audit of 3322 patients undergoing cardiac surgery.
Transfusion 2016; Apr 26 [Epub ahead of print].

#

NATA REVIEW:
With the improvements made in non-invasive cardiac therapies (e.g. percutaneous transluminal coronary angioplasty)...
REVIEW by:
D. Faraoni

Published: Jan 2016

Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM

The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial.
Ann Surg 2016; Jan 27 [Epub ahead of print].

#

NATA REVIEW:
In this study, patients with confirmed iron-deficiency anaemia (IDA) scheduled for major abdominal surgery (mostly...
REVIEW by:
M. Muñoz

Published: Dec 2015

Siegal DM, Curnutte JT, Connolly SJ, et al.

Andexanet alfa for the reversal of factor Xa inhibitor activity.
N Engl J Med 2015;373:2413-2424

#

NATA REVIEW:
The direct factor Xa inhibitors apixaban and rivaroxaban are increasingly used for the prevention and the...
REVIEW by:
D. Faraoni

Published: Dec 2015

Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al.

Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial.
JAMA 2015;314:2514-2523.

#

NATA REVIEW:
Over the past few years, the "age of blood" has been one of the hot topics discussed regularly during meetings...
REVIEW by:
J. Meier

Published: Dec 2015

Ding YY, Kader B, Christiansen CL, Berlowitz DR

Hemoglobin level and hospital mortality among ICU patients with cardiac disease who received transfusions.
J Am Coll Cardiol 2015;66:2510-2518.

#

NATA REVIEW:
This is an interesting investigation which serves to better inform healthcare providers in their clinical decision-making...
REVIEW by:
C. G. Koch